Opendata, web and dolomites

ASTROCIT

Development and validation of an innovative nutritional solution to fight muscle atrophy during human space flights, application of the acquired knowledge to prevent muscle degeneration down on earth

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ASTROCIT project word cloud

Explore the words cloud of the ASTROCIT project. It provides you a very rough idea of what is the project "ASTROCIT" about.

bettering    lasting    commercializing    diet    human    prevent    protocol    physiotherapists    scientific    degeneration    routine    muscular    aged    answer    preventive    muscle    quality    bioavailability    someone    health    public    commercially    50    combination    nutraceutical    life    fight    feasibility    thereby    acids    galenics    mass    older    innovative    gerontologists    astrocit    formulation    severely    instance    deliverable    space    amino    compounds    collecting    surgery    astronaut    efficiency    opportunity    spending    quantify    plan    revolutionize    satisfactory    autonomy    cared    immobilization    consolidating    underwent    solutions    medical    reducing    hitherto    unseen    giving    solution    ageing    mitigate    people    ease    astronauts    validate    physicians    atrophy    compliancy    missions    updated    first    flights    effect    benefit    expertise    lose    performance    exercise    data    strategy    accessing    clinical    weightlessness    hardly    risks    therapeutic    ip    proven    business    person    seize    citrage    financial    backing    serious    question    industrial    earth    nutrition    huge    injured   

Project "ASTROCIT" data sheet

The following table provides information about the project.

Coordinator
CITRAGE 

Organization address
address: 94 AV GENERAL DE GAULLE
city: CRETEIL
postcode: 94019
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Project website http://www.citrage.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.6. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Space)
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-03-01   to  2016-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    CITRAGE FR (CRETEIL) coordinator 50˙000.00

Map

 Project objective

Question: What is the common factor between an astronaut, an older person and someone who just underwent a serious surgery? Answer: Muscle atrophy. During long missions for instance, astronauts can lose up to 50% of their muscle mass severely affecting their performance and health. The only commercially available solutions hardly able to mitigate the effect of weightlessness, ageing and immobilization are exercise and diet but they are not satisfactory in terms of efficiency, ease-of-use, bioavailability, compliancy or scientific backing. AstroCIT’s objective is to develop and validate an innovative nutraceutical to fight muscle loss during human space flights and prevent muscular degeneration on earth. It will revolutionize how muscle atrophy is cared for by giving space physicians, gerontologists and physiotherapists an effective preventive and therapeutic solution, thereby enabling astronauts to be more operational, bettering quality of life in space, improving autonomy of aged or injured people and reducing public spending. This new nutraceutical is based on CITRAGE’s and its partners’ long lasting expertise in developing and commercializing amino acids based products applied to the combination of a proven and a hitherto unseen compounds. During phase 1, CITRAGE will scale-up the project by (a) defining the best formulation and galenics for the product, (b) accessing data generated by other research projects in the field of nutrition and muscle atrophy, (c) collecting medical and financial data to further quantify the technology’s benefit and its risks, (d) defining the protocol of a EU clinical study to be implemented in phase 2 and (e) consolidating the IP strategy. The main deliverable will be an updated business plan enabling CITRAGE to seize this huge business opportunity of further exploiting their know-how in space and down on earth. This feasibility study is an essential first step before routine use and industrial production.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ASTROCIT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ASTROCIT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.6.;H2020-EU.2.3.1.)

ReadyToSail (2016)

ReadyToSail

Read More  

HEART (2018)

HIGH HEAT REJECTION THERMAL CONTROL SYSTEM

Read More  

HELIUM (2015)

High European Laboratory for Institutes, Universities and Markets

Read More